Last update 27 Feb 2026

Yishen Huazhuo Granules

Overview

Basic Info

Drug Type
Herbal medicine
Synonyms-
Target-
Action-
Mechanism-
Therapeutic Areas
Immune System DiseasesUrogenital DiseasesOther Diseases
Active Indication
Idiopathic Membranous GlomerulonephritisKidney Failure, Chronic
Inactive Indication
Glomerulonephritis, IGA
Originator Organization-
Active Organization
Beijing Estone Science and Technology Development Co., Ltd.Beijing Estone Science and Technology Development Co., Ltd.Tianjin Institute of Pharmaceutical Research Co., Ltd.Tianjin Institute of Pharmaceutical Research Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

7
Clinical Trials associated with Yishen Huazhuo Granules
CTR20231082
/ RecruitingPhase 2
益肾化浊颗粒治疗特发性膜性肾病低风险人群（脾肾气虚血瘀证）评价其有效性和安全性的随机双盲、剂量探索、平行对照、多中心Ⅱb期临床试验
[Translation] A randomized, double-blind, dose-finding, parallel-controlled, multicenter phase IIb clinical trial to evaluate the efficacy and safety of Yishen Huazhuo granules in the treatment of low-risk population (spleen and kidney qi deficiency and blood stasis syndrome) with idiopathic membranous nephropathy
ChiCTR2300070304
/ RecruitingPhase 2IIT
A clinical trial of Yishen Huazhuo granules for the treatment of low risk patients with idiopathic membranous nephropathy (spleen and kidney qi deficiency and blood stasis syndrome)
CTR20170821
/ TerminatedPhase 2
益肾化浊颗粒治疗IgA肾病（脾肾气虚血瘀证）的有效性和安全性的多中心、随机、双盲、剂量平行对照Ⅱa期临床试验
[Translation] A multicenter, randomized, double-blind, dose-controlled phase IIa clinical trial to evaluate the efficacy and safety of Yishen Huazhuo granules in the treatment of IgA nephropathy (spleen and kidney qi deficiency and blood stasis syndrome).
100 Clinical Results associated with Yishen Huazhuo Granules
Login to view more data
100 Translational Medicine associated with Yishen Huazhuo Granules
Login to view more data
100 Patents (Medical) associated with Yishen Huazhuo Granules
Login to view more data
100 Deals associated with Yishen Huazhuo Granules
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Idiopathic Membranous GlomerulonephritisPhase 2
China
Tianjin Institute of Pharmaceutical Research Co., Ltd.Tianjin Institute of Pharmaceutical Research Co., Ltd.
23 Aug 2023
Glomerulonephritis, IGAPhase 2
China
Tianjin Institute of Pharmaceutical Research Co., Ltd.Tianjin Institute of Pharmaceutical Research Co., Ltd.
04 Feb 2021
Glomerulonephritis, MembranousPhase 2
China
Tianjin Institute of Pharmaceutical Research Co., Ltd.Tianjin Institute of Pharmaceutical Research Co., Ltd.
31 Jul 2019
Kidney Failure, ChronicPhase 2
China
Beijing Estone Science and Technology Development Co., Ltd.Beijing Estone Science and Technology Development Co., Ltd.
29 Apr 2014
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free